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Anticancer Effect of Capsaicin  
and Its Analogues
Balasubramanian Arul and Ramalingam Kothai
Abstract
Potent biomolecules from natural products from plants, animals, and minerals 
are the fundamental basis of the ailment of mankind. Capsicum or red pepper plants 
were grouped under the kingdom Plantae and family Solanaceae. It is used widely 
throughout the world in foods for their pungent flavor and aroma, and to prolong 
food spoilage. This chapter presents a frame of a concise compilation of the anti-
cancer and cytotoxic potentials of Capsicum, its analogs, and related compounds. 
Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is the most predominant 
and naturally occurring alkaloid from the Capsicum species. It also details the 
anticancer efficacy of capsaicin and its analogs like capsaicinoids and capsiates 
which possess antioxidants and targets multiple signaling pathways, ontogenesis, 
and tumor-suppressor genes in various types of cancer models. Capsaicin is a major 
ingredient and has been linked to suppression of growth in various cancer cells. The 
data available strongly indicate the significant anticancer benefits of capsaicin and 
its potent analog molecules. It shows a significant effect on cancer cell proliferation, 
apoptosis, cancer cell surveillance, growth arrest, and metastasis. This chapter also 
predominantly focuses on the combinational use of capsaicin with other natural 
dietary compounds as a measure of synergistic anticancer activities.
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1. Introduction
Capsicum is one of the most important genera in the Solanaceae family and 
consists of almost 30 species [1]. Their fruits were commonly referred to as pep-
pers or chili peppers, having a bell shape that appears in different colors such as 
red, green, orange, and yellow. These have been commonly used in their diet by 
human society from ancient times as herb and spice. Capsicum is widely used as an 
essential ingredient in kitchens worldwide for their pungent flavor and scent and 
to prevent food contamination. It is known under many names, such as red pep-
per, chili pepper, paprika, tabasco, aji, cayenne, and tabasco jalapeno, because of 
its global consumption [2]. The genus Capsicum is comprised of various numbers 
of wild and few domestic species. The species domesticated are Capsicum annum, 
C. baccalaureus, C. honey, C. frutescens, C. pudders, in which C. chinense is the fruit 
with the highest pungency [3]. Capsicum has been documented for its wide range 
of activities, such as pain killers, cardiovascular protection, a cancer chemopreven-
tive, and antioxidant effects. This chapter provides a comprehensive description of 
the capsaicin and its analogs as well as, more specifically, look into its therapeutic 
potential in various human cancer and future therapeutic directions of capsaicin.
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2. Capsaicinoids
The chili-fruit pungent principles are called capsaicin. Capsaicin and many 
related compounds are called capsaicinoids. Capsaicin (trans-8-methyl-N-vanillyl-
6-nonenamide) is a crystalline, lipophilic, colorless, and odorless alkaloid that is sol-
uble in fat, alcohol, and oil. The major capsaicinoids or the analogs from Capsicum 
annum species are Capsaicin and 6,7-dihydrocapsaicin. The smaller capsaicinoids 
are nordihydrocapsaicin, homodihydrocapsaicin, and homocapsaicin. Capsaicin 
and their analogs differ only in acyl group saturation [4, 5]. These alkaloids are 
produced solely by the genus Capsicum, and they are used as a potent analgesic for 
the treatment of pain and inflammation related to a number of diseases [6, 7].
Although capsaicin traditionally is associated with the analgesic activity, its 
unpleasant side effects, such as gastric irritation, stomach cramps, and burning 
sensation, limit capsaicin’s applications as a clinically viable drug. This has led 
to extensive research focusing on the discovery and rational design of capsaicin 
analogs of the second generation, which have greater bioactivity than capsaicin. 
Modifications in the acid portion of capsaicin were found to generate analogs with 
different degrees of pungency. Three capsaicin analogs of two pungent and one 
with very low pungency were obtained by using multiple lengths of the acyl chain 
and chemical replacements in the aromatic ring [8]. The chemical structure of 
capsaicin and its analogs [9, 10] were shown in Figure 1.
Capsaicin (Figure 1(1)) and its analogs such as capsanthin (Figure 1(2)), 
capsanthin 3′-ester (Figure 1(3)), capsanthin 3′,3-diester (Figure 1(4)), capsoru-
bin (Figure 1(5)), capsorubin 3′-ester (Figure 1(6)), and capsorubin—3,6-epoxide 
(Figure 1(7)) containing pharmaceutical products have been marketed under the 
trade name such as Menthacin, Zostrix, and Capzasin-P for topical applications. In 
2009, the European Union (EU) and the USA Food and Drug Administration (FDA) 
Figure 1. 
Capsaicin and its analogs: (1) capsaicin; (2) capsanthin; (3) capsanthin 3′-ester; (4) capsanthin 3′,3-diester; 
(5) capsorubin; (6) capsorubin 3′-ester; (7) capsorubin—3,6-epoxide.
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approved the use of capsaicin 8% patch (Qutenza or NGX-4010) for the treatment 
of post-herpetic neuralgia (PHN). Resiniferatoxin (RTX) is regarded as an ultra-
potent analog of capsaicin that acts as an agonist of Transient receptor potential 
cation channel subfamily V member 1 (TRPV1) and displays several thousand-fold 
more potencies than capsaicin [11]. Zucapsaicin, the cis-isomer of capsaicin, shows 
potent efficacy against episodic cluster migraine prophylaxis, episodic cluster 
headache, and alleviates neuropathic pain [12]. Thus, capsaicin and its analogs have 
been used medicinally for centuries, but recently, it has been studied extensively 
for its analgesic, antioxidant, anti-inflammatory, anti-obesity characteristics and 
currently for its anticancer activity against a number of types of cancer [13]. It was 
witnessed by unparalleled advances in the field of capsaicin research. These stud-
ies and several other reports clearly showed that capsaicin and its analogs possess 
multiple pharmacological effects and its application in different clinical conditions.
3. Anticancer activity of capsaicin and its analogs
There is a strong epidemiological and experimental evidence that the phyto-
chemical diet found in fruits, vegetables, whole grains, spices, and teas provides 
various inhibitory effects against the initiation, development, progression, and 
metastasis of cancer [14]. Capsaicin, a bioactive phytochemical abundant in chili 
peppers, is in between them. Capsaicin is a derivative of homovanillic acid, which 
has been shown to modify the function of many genes associated with cancer cell 
life span, growth arrest, angiogenesis, and metastasis [15, 16].
Tumorigenesis is a multistage process, which usually begins over an extended 
period. Cancer cells develop special properties not acquired by most healthy cells. 
Multiple genetic alterations and aberrant signaling pathways initiate and advance 
cancer. Determining the molecular targets involved in the tumor development 
process will provide opportunities to develop a successful cancer-fighting strategy. 
Studies assessing the capsaicin effect to inhibit cell proliferation by mechanisms are 
not fully understood in many types of cancer cells [17]. The capsaicin’s suggested 
anticancer pathways include increased cell cycle arrest and apoptosis.
3.1 Capsaicin and apoptosis
Apoptosis is a vital mechanism against the growth of cancer, and it is strongly 
correlated with the loss of apoptotic signals in malignancy. It has been shown that 
capsaicin induces apoptosis in many different types of cancer cell lines, including 
pancreas, colon, prostate, liver, esophagus, bladder, skin, leukemia, lung, and endo-
thelial cells, keeping the normal cells unharmed. A recent review noted capsaicin 
appears to induce apoptosis in more than 40 distinct lines of cancer cells [13, 18].
Two major signaling systems are the intrinsic mitochondrial death pathway 
and the extrinsic death receptor pathway, which activate executioner/effector 
caspases and lead to apoptosis. In specific, the mitochondrial pathway is involved 
in the complete execution of apoptosis; thus, the mitochondrion has been named as 
apoptotic mechanism’s gatekeeper, and the mitochondrial death pathway proteins 
and pathways had become important targets for new treatments [19]. Many pro-
teins involved in the mitochondrial death pathway have been targeted by capsaicin 
to induce apoptosis in different cancer cell lines. For instance, capsaicin treatment 
activated the cluster of differentiation 95 (CD95)-mediated apoptotic intrinsic and 
extrinsic pathways [20] and suppressed antiapoptotic protein expression, B-cell 
lymphoma 2, which causes caspase-9 and -3 activation, loss of mitochondrial 
membrane potential, and subsequent rises in cytochrome c release [21].
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Capsaicin’s proapoptotic activity has been found to be mediated via transient 
vanilloid potential receptor (TRPV1) in many types of cancers [21–23]. It is a 
nonselective cation channel pertaining to the transient receptor potential channel 
(TRP) family [24]. It does prefer Ca2+ to Na+. Thus it contributes to changes in the 
concentration of cytosolic free Ca2+ and it is capsaicin’s primary cell target.
3.2 Reactive oxygen species
Earlier research in pancreatic cells showed that the apoptosis effects of capsaicin 
were correlated with reactive oxygen species (ROS) production, c-Jun N-terminal 
Kinase (JNK) activation, mitochondrial depolarization, cytochrome c release in 
the cytosol, and caspase-3 cascade activation [25]. There is also quite a complex 
relationship that exists between capsaicin exposure and ROS production. ROS is 
conventionally considered cytotoxic and mutagenic in normal cells and can induce 
cell death, apoptosis, and senescence at high levels [26].
Capsaicin has been suggested to induce apoptosis in cancerous cells through the 
production of higher rates of intracellular ROS. This observation reveals capsaicin 
as the primary signaling molecule [27, 28]. Capsaicin is capable of activating apop-
tosis through nonreceptor mechanisms [25].
A number of studies in recent years have shown that oxidative stress causes 
cellular apoptosis through both mitochondria-dependent and mitochondria-
independent pathways [29].
Mitochondria account for 50% of the total cytoplasmic volume in most cells 
and they participate more than any other organelle in metabolic functions, par-
ticularly those involved in cellular energy production. It also consumes nearly 90% 
of cellular oxygen and is the main source of ROS produced during breathing, and 
it is engaged in maintaining the intracellular redox state. Along with their long-
standing role in energetics, mitochondria depict its prime focus in mammalian cells 
for many cell death signals. Interactions at the mitochondrion eventually determine 
whether a cell survives or dies in reaction to many physiological or therapeutic 
stimuli of cell death. A number of proteins involved in the mitochondrial death 
pathway were shown to be targeted by capsaicin in order to initiate apoptosis in 
various cancer cell lines.
It was reported that a 12-h exposure to high concentrations of capsaicin was 
necessary to induce higher apoptosis rates in Cellosaurus Colo 16 (COLO 16) cells 
[26]. More than half experienced apoptosis, which was correlated with progressive 
irreversible dispersion of mitochondrial transmembrane potential and elevated 
superoxide levels, illustrates the destruction of mitochondria and subsequent 
breakdown of mitochondrial electron transfer.
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is a part of the 
complex I of the mitochondrial electron transport chain. Capsaicin has been shown 
to specifically inhibit mitochondrial NADPH oxidase activity by competitively 
binding this enzyme to the ubiquinone/coenzyme Q site. Therefore, if capsaicin 
blocks the transportation of electrons in mitochondria, irreversible dispersion of 
mitochondrial transmembrane potential will occur. This will initiate apoptosis and 
change the mitochondrial permeability to release cytochrome c and eventual activa-
tion of proapoptotic pathways.
Capsaicin can block NAPDH oxidase in the plasma membrane by acting as a Q 
antagonist coenzyme. Capsaicin’s vanillyl moiety is structurally similar to coenzyme 
Q’s cyclic part, which could address the fact that vanilloids serve as antagonists to 
the coenzyme Q. Suppression of plasma membrane NAPDH oxidase was correlated 
with capsaicin’s prooxidant and proapoptotic properties in some transformed cells, 
and activated T cells [30].
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Another mechanism proposed by capsaicin’s anticancer activity is interac-
tion with AMP-dependent protein kinase (AMPK), which is the cell’s primary 
metabolic gatekeeper, belonging to the family of protein kinase stimulated during 
enzyme-depleting metabolic states like hypoxemia, thermal shock, oxidative 
stress, and physical activity. It acts as a significant metabolic transition for 
maintaining energy homeostasis and shown to be an intrinsic controller of the 
mammalian cell cycle [31, 32].
There is an increase in intracellular Adenosine diphosphate (ADP)/Adenosine 
triphosphate (ATP) and/or Adenosine monophosphate (AMP)/ATP ratios [33] dur-
ing energetic imbalance and it promotes activation of AMPK. Activation of AMPK 
increases oxidative stress in many human cancer cells and induces apoptosis. This 
stimulates catabolic pathways and, at the same time, inhibits the rate of anabolic 
reactions to regain the correct energy charge for adenylates.
Capsaicin treatment of human colorectal adenocarcinoma (HT29) cell line is 
shown to cause AMPK activation and inhibition of acetyl-CoA carboxylase (ACC), 
a well-known AMPK substrate, which indicates capsaicin inhibits lipid biosynthe-
sis. The above concepts were implicated in apoptosis caused by capsaicin.
3.3 Capsaicin and cell cycle
The cycle of cells is a series of stages that cells undergo to allow them to divide 
and produce new cells. The cell cycle is divided into phases G0/G1, S, and G2/M 
stages. The cyclins, cyclin-dependent kinases (CDKs), and the CDK inhibitors are 
essential parts of the cell cycle. There are DNA checkpoints to assure DNA replica-
tion integrity. Such checkpoints and repair pathways render cellular responses to 
damage to DNA easier [14]. When stimulated, the CDKs provide the cells with 
a driving force to pass from one stage to the next, but if cyclin and/or CDKs are 
impaired, cell cycle arrest [17, 33, 34] happens. Thus, any alteration in these path-
ways raises the cancer risk. It was reported that capsaicin inhibits CDK2, CDK4, 
and CDK6 inhibiting the proliferation of 5637 bladder carcinoma cells via cycle 
arrest [34].
3.4 Capsaicin and p53
The p53 tumor suppressor prevents cell proliferation by inducing cell cycle 
arrest and apoptosis in response to cell stress such as damage to DNA, hypoxia, and 
activation of oncogenes. Phosphorylation is critical for p53-dependent transactiva-
tion at the Ser-15 residue [17]. P53 promotes apoptosis by a linear pathway involv-
ing Bax transactivation, cytosol-to-membrane Bax translocation, mitochondrial 
cytochrome c release, and caspase-9 activation, followed by caspase-3, -6, and -7 
activation. Research studies indicate p53 is a target of capsaicin’s anticancer action. 
Capsaicin was found to induce p53 phosphorylation of residue Ser-15 and enhanced 
p53 acetylation by sirtuin 1 downregulation, which is responsible for the initiation 
of apoptosis [35].
Incubated adenocarcinoma gastric cell line (AGS) of human gastric cancer 
with different capsaicin concentrations in the presence and absence of p53 siRNA 
showed that capsaicin induces apoptosis via p53 upregulation in AGS cells and that 
the apoptotic effect of capsaicin is p53-dependent [36]. It also observed that the 
tendency of capsaicin to induce the expression of proapoptotic proteins, such as 
Bax, caspase-3, and caspase-8, was almost entirely diminished by hitting down p53. 
Effects of capsaicin on the same cell type reported that caspase-3 activity increased 
with capsaicin exposure, indicating that capsaicin may serve as an anti-tumorigenic 
agent in human gastric cancer [37].
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3.5 Capsaicin and β-catenin
β-catenin is a beneficial 90 kD protein that leads to cell growth under normal 
physiological conditions. It is a key transcription factor in the signaling of Wingless-
Int (Wnt) and plays a vital role in stem cell regeneration and organ regrowth. 
Abnormal expression of β-catenin causes the malignant conversion of normal cells, 
and its anomalous activity has been documented in several cancer types. β-catenin 
is essentially active in many types of cancer cells. In a recent study, it was reported 
that capsaicin downregulated β-catenin transcription, decreased its protein stabil-
ity, and caused apoptosis of colorectal cancer cells [38].
3.6 Capsaicin and angiogenesis
Angiogenesis is the development of new blood vessels from preexisting vascu-
lature as well as an important homeostatic process for normal wound healing and 
embryonic growth. It involves the stimulation of endothelial cells, cell proliferation, 
invasion, chemotactic migration, and differentiation into new blood vessels [39]. 
Angiogenesis is a central player in cancer cell growth and tumor metastasis. The 
development of an angiogenic phenotype is regarded as a vital step in the progres-
sion of tumors [40, 41]. The cancer cells grew to 1–2 mm3 in thickness in absence of 
circulation and stopped, but in the angiogenic area, they expanded beyond 2 mm3. 
Tumors can become necrotic or even apoptotic in the absence of vascular support 
[42]. Thus, angiogenesis is a significant factor in cancer progression.
Some factors such as growth factors, cytokines, and vascular endothelial 
growth factor (VGEF) regulate angiogenesis. Nevertheless, VEGF plays a signifi-
cant role in angiogenesis. In addition, endothelial cells produce growth factors 
that induce autocrine and paracrine growth of tumors. The initiation of angio-
genesis correlates with the increased entry into the circulation of neoplastic cells 
and thus promotes metastasis [43]. Treatment of endothelial cells with capsaicin 
blocked the sprouting and development of VEGF-induced vessels in Matrigel 
mouse assay that was correlated with downregulation of p38 mitogen activated 
protein kinases (MAPK), protein kinase B (PKB), and focal adhesion kinase 
(FAK) activation [44, 45].
Furthermore, capsaicin enhanced deterioration of hypoxia-inducible factor1α, 
which is a crucial transcription factor rising VEGF transcription. Capsaicin thus 
interferes with typical angiogenic signaling pathways and can have the ability to 
suppress cancer becoming a malignant one. It was reported that capsaicin’s anti-
angiogenic activity was associated with reduced cyclin D1 expression, which results 
in decreased Rb phosphorylation, leading to the GI arrest of human endothelial 
cells of the umbilical cord (HUVEC) [46]. In addition, capsaicin also inhibited focal 
adhesion kinase (FAK) and p38 kinase activation caused by VEGF. All of the above 
results indicate that capsaicin is a dietary anti-angiogenic agent.
3.7 Capsaicin and metastasis
Cancer metastasis is the hallmark of tumor malignancy, which starts with the 
spread of cancer cells from the principal tumor to nearby tissues and distant organs, 
and it is the main cause of cancer morbidity and mortality. Metastatic cancer is 
resistant to treatment and contributes 80% of cancer-related deaths, which remains 
a great problem for cancer therapy [47]. Invasion and movement of tumor cells 
include the proteolytic degradation of extracellular matrix components by tumor 
cell-secreted proteases, involving serine proteases, plasminogen activators, and 
matrix metalloproteinases (MMPs).
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Cancer type Cell line Effective 
doses (μM)
Anticancer mechanism
Human colorectal 
cancer
HCT 116 100–200 Induced autophagy
LoVo, SW480 100 Induced anti-tumorigenesis; deregulation of 
β-catenin/TCF-dependent signaling
Colo 205 150 Induced cell death, increased ROS, and 
proapoptotic proteins
Human breast cancer MCF-7 50–300 Induced autophagy, inhibited growth, and 
induced apoptosis
T47D, BT-474, 
SKBR-3
200 Inhibited growth and increased apoptosis
MDA-MB231 20–200 Induced apoptosis and dysfunctions in 
mitochondria. Antiproliferative activity 
and arrest of cell cycle into G2/M phase. 
Enhances the apoptotic effects of TRIAL by 
activating the calcium-CaMKII-Sp1 pathway
Human prostate 
cancer
LNCaP 40–50 Inhibited proliferation and induced 
apoptosis
PC-3 20–50
DU-145 500
RWPE-1 40
Human myeloid 
leukemia
HL-60 >50 Induced G0/G1 phase cell cycle arrest and 
apoptosis
U937, THP-1 200 Enhances the apoptotic effects of TRIAL by 
activating the calcium-CaMKII-Sp1 pathway
Human esophageal 
epidermoid 
carcinoma
CE 81 T/VGH 100 Induced apoptosis and G0/G1 phase cell 
cycle arrest
Human melanoma A375 100 Inhibited cell growth and promoted 
apoptosis
Human KB cancer 
cells
KB cells 150–200 Reduced cell proliferation and viability. 
Induced cell death and cell cycle arrest in 
G2/M phase
Mouse melanoma B16-F10 50 Inhibited cell migration. Induced apoptosis
Human pancreatic 
cancer
AsPC-1, 
BxPC-3
150 Inhibited proliferation. Induced apoptosis 
and generated ROS
PANC-1 200 Induced G0/G1 phase cell cycle arrest and 
apoptosis; and inhibited growth
Human multiple 
myeloma
U266, MM.1S >5 Inhibited cell proliferation, caused 
accumulation of cells in G1 phase
Human hepatoma Hep G2 10–200 Decreased cell viability, generated ROS and 
activated caspase-3; and induced apoptosis 
and autophagy
Hep3B 200 Enhances the apoptotic effects of TRIAL by 
activating the calcium-CaMKII-Sp1 pathway
Human 
nasopharyngeal 
carcinoma
NPC-TW 039 200–400 Induced G0/G1 phase arrest and apoptosis. 
Increased ROS
Human gastric 
carcinoma
SMC-1 200 Induced apoptosis
Human bladder 
cancer
T24 100 Induced ROS production and mitochondrial 
membrane depolarization
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Capsaicin revealed its anti-invasive and anti-migratory activity by modulating 
signaling pathways including cell invasion and migration and suppressing advanced 
cancer stages. Treatment with capsaicin significantly reduced the metastatic burden 
in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice. It has been 
reported that it significantly inhibited the migration of melanoma cells without 
leading to apparent cellular cytotoxicity [48]. This effect was associated with the 
downregulation of the signaling cascade of phosphoinositide 3-kinase (PI3 K) and 
reduction of the RAS-related c3 botulinum toxin substrate 1 (RAC1), which in itself 
is the main kinase controlling motility and migration of cells. Capsaicin blocked the 
invasion and migration of human fibrosarcoma cells triggered by epidermal growth 
factor (EGF) by downregulation of AKT/FAK, extracellular signal-regulated 
kinases, and p38 MAPK signaling, and subsequent downregulation of matrix metal-
lopeptidase 9 (MMP9) in invasive fibrosarcoma cells.
Thereby, capsaicin recruits several mechanisms of signaling for controlling 
migration and invasion. These include epithelial-mesenchymal transition (EMT) 
activation, AMP-activated protein kinase (AMPK), MMP signaling pathway, 
intracellular calcium elevation, VEGF, Wnt-Hedgehog control, tumor-associated 
NADH oxidase (tNOX), protein kinase B (Akt), MMPs, epidermal growth factor 
receptor (EGFR), extracellular signal-regulated kinase (ERK), p38 MAP kinase, 
RAC1, nuclear factor “kappa-light-chain-enhancer” of activated B-cells (NF-kB), 
and AP-1 [49–54]. Table 1 depicts the anticancer potential of capsaicin against 
various cancer cell lines.
4. Synergistic anticancer activity of capsaicin with other compounds
Recent development has allowed synergistic drugs to treat a wide array of can-
cers. Combinations of low doses of chemopreventive agents have progressively been 
used clinically in the treatment of various cancers in the present days. Compared to 
the traditional single drug policy, the combination strategy increases therapeutic 
effects or reduces drug resistance [55]. Computational progress in qualitatively 
testing and predicting synergistic components has been experienced in the last few 
years [56–58]. Multiple studies have illustrated that novel combination therapies 
with different phytochemicals and chemopreventive drugs can elicit increased 
antitumor activity through additive or synergistic action [59, 60].
The pathways can include parallel action on cancer suppression by modifying 
carcinogen detoxification and metabolism of hormones, scavenging oxidative 
stress, and enhancing immunity [61–63]. Hundreds of phytochemicals have various 
physicochemical and kinetic properties that target different signaling pathways and 
transcription factors that decide the phenotype of cancer. The use of several bioac-
tive compounds with distinct anticancer pathways could, therefore, be a promising 
method for successful cancer treatment and prevention.
Cancer type Cell line Effective 
doses (μM)
Anticancer mechanism
Human small cell 
lung cancer
NCI-H69, 
NCI-H82, 
DMS53, 
DMS114
50 Suppressed growth in all four cell lines
TCF: T-cell factor; ROS: reactive oxygen species; TRIAL: TNF-related apoptosis-inducing ligand; CaMKII-Sp1: 
calcium-calmodulin-dependent kinase II signaling pathway I.
Table 1. 
Anticancer potential of capsaicin against various cancer cell lines.
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Capsaicin and other compounds are known to have synergistic anticancer 
properties. Combined with resveratrol, capsaicin facilitated apoptosis by elevating 
nitric oxide (NO) via a p53-dependent manner [64]. It has synergistic anticancer 
activity with pirarubicin, an anthracycline drug, by activating TRPV1 in bladder 
cancer [65]. Capsaicin shows a synergistic effect with the dietary phytoestrogen, 
genistein by regulation of AMPK and cyclooxygenase 2 in breast cancer cells [66]. 
Capsaicin and 3,3′-diindolylmethane, a key in vivo metabolite of indole-3-carbinol, 
abundantly present in cruciferous vegetables, have recently been reported to work 
synergistically to induce apoptosis in colorectal cancer, by altering the transcrip-
tional function of the nuclear factor kappa B, p53, and control apoptosis-related 
genes [67]. Capsaicin, and brassinin, a form of indole derived from cruciferous 
vegetables, showed synergistic anticancer activity by suppressing MMP2 and -9 
expression and enzymatic activities, and invasion, and migration of prostate carci-
noma cells [68]. Sometimes, capsaicin also interacts with chemotherapy drugs. For 
example, in some myeloid leukemia cells [69], capsaicin enhanced the therapeutic 
efficacy with 12-O-Tetradecanoylphorbol-13-acetate. Capsaicin can, surprisingly, 
affect the viability of cancer stem cells. Capsaicin has been found to cause cancer 
stem cell death by inhibiting the NOTCH signaling pathway in stem cells of breast 
cancer [70].
5. Conclusion
An emerging cancer research area is the search for suitable molecular targets 
and effective anticancer compounds that modify the cancer targets. Capsaicin 
exhibits significant anticancer activity in various tumor stages by targeting multiple 
signaling pathways and cancer-associated genes. As a whole, capsaicin’s anticancer 
pathways involve apoptosis initiation, cell growth arrest, and suppression of angio-
genesis and metastasis. Capsaicin and its analogs activate the tumor-suppressive 
signaling pathway and associated transcription factors while inhibiting oncogenic 
signaling pathways and cancer cell promoters. In addition, capsaicin acts synergisti-
cally with other anticancer agents, allowing for the potential use of capsaicin with 
other chemotherapeutic agents in cancer therapy, and shows double advantage, 
i.e., capsaicinoids enhances the chemotherapeutic effect and pain relief for cancer 
patients. More research on capsaicin’s and its analogs as anticancer targets holds the 
potential for future treatments and requires more study to improve our understand-
ing of its efficacy in cancer treatment and prevention.
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